Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Is February 19 A Dry Day In Mumbai? Check Other Dates When There Will Be Complete Alcohol Ban In Mumbai-Maharashtra & Delhi
'Woh Hame Nayi Urja Dete Hai...': Riteish Deshmukh Celebrates Chhatrapati Shivaji Maharaj Jayanti At Shivneri Fort In Pune - Watch Video
AI Biggest Platform Shift Of Our Lifetimes; India's Vizag Emerging As Global AI Hub: Google CEO Sundar Pichai
'AI Next Big Infrastructure Like Electricity & Internet, Must Reach Every Citizen': Tata Sons Chairman N Chandrasekaran At AI Summit Inauguration Ceremony In Delhi
(With inputs from PTI)
